Stability of Programmable Shunt Valve Settings with Simultaneous Use of the Optune Transducer Array: A Case Report

The Optune® transducer array (Novocure Ltd., Haifa, Israel) is an FDA-approved noninvasive regional therapy that aims to inhibit the growth of glioblastoma multiforme (GBM) cells via utilization of alternating electric fields. Some patients with GBM may develop hydrocephalus and benefit from subsequ...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Andrew K, Birk, Harjus S, Winkler, Ethan A, Viner, Jennifer A, Taylor, Jennie W, McDermott, Michael W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2016
Materias:
Neurosurgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977218/
https://www.ncbi.nlm.nih.gov/pubmed/27551653
http://dx.doi.org/10.7759/cureus.675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977218/
https://www.ncbi.nlm.nih.gov/pubmed/27551653
http://dx.doi.org/10.7759/cureus.675

Ejemplares similares